These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1376067)

  • 1. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
    Paglieroni T; MacKenzie MR; Caggiano V
    Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
    [No Abstract]   [Full Text] [Related]  

  • 2. B-1 (CD 5+) B-cells as a marker of immune dysregulation in multiple myeloma.
    MacKenzie MR; Paglieroni TG
    Curr Top Microbiol Immunol; 1995; 194():51-6. PubMed ID: 7534673
    [No Abstract]   [Full Text] [Related]  

  • 3. CD19 and immunophenotype of bone marrow plasma cells in monoclonal gammopathy of undetermined significance.
    Zandecki M; Facon T; Bernardi F; Izydorczyk V; Dupond L; François M; Reade R; Iaru T; Bauters F; Cosson A
    J Clin Pathol; 1995 Jun; 48(6):548-52. PubMed ID: 7545187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients.
    Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM
    Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
    Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
    Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in immune regulation precede the development of multiple myeloma.
    Paglieroni T; Caggiano V; MacKenzie M
    Am J Hematol; 1992 May; 40(1):51-5. PubMed ID: 1373558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5 B lymphocyte antigen in monoclonal gammopathy.
    Bataille R; Duperray C; Zhang XG; Brochier J; Klein B
    Am J Hematol; 1992 Oct; 41(2):102-6. PubMed ID: 1384312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serial study of CD5+ and CD5- B cell subpopulations in 335 HIV seropositive patients.
    Vuillier F; Scott-Algara D; Tortevoye P; Pialoux G; Dighiero G
    Clin Exp Immunol; 1991 Sep; 85(3):476-80. PubMed ID: 1716542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell number and function in Graves' disease.
    Wilson R; Pearson C; McKillop JH; Thomson JA
    Autoimmunity; 1994; 17(3):251. PubMed ID: 7524703
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenotypic and functional abnormalities of B cells in myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 1993 Jun; 681():256-63. PubMed ID: 7689307
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
    Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
    J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increase of CD5LOW+NK cells in patients with multiple myeloma and plasmacytoma.
    Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N
    Anticancer Res; 1994; 14(2B):725-30. PubMed ID: 7516640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the expression of CD5 by human B cells and correlation with functional activity.
    Vernino LA; Pisetsky DS; Lipsky PE
    Cell Immunol; 1992 Jan; 139(1):185-97. PubMed ID: 1370255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.
    Neil GA; Summers RW; Cheyne BA; Capenter C; Huang WL; Kansas GS; Waldschmidt TJ
    Dig Dis Sci; 1992 Sep; 37(9):1390-5. PubMed ID: 1380423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD5+ B cells as precursors of CD5- IgG anti-DNA antibody-producing B cells in autoimmune-prone NZB/W F1 mice.
    Kanno K; Okada T; Abe M; Hirose S; Shirai T
    Ann N Y Acad Sci; 1992 May; 651():576-8. PubMed ID: 1376080
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment and characterization of a CD5 positive, immunosuppressive human myeloma cell line.
    Scibienski RJ; Paglieroni TG; MacKenzie MR
    Leukemia; 1990 Nov; 4(11):775-80. PubMed ID: 1700238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of interleukin-3 and interleukin-6 on peripheral blood cells from multiple myeloma patients and their clinical significance.
    Goto H; Shimazaki C; Ashihara E; Ohkawa K; Oku N; Inaba T; Murakami S; Fujita N; Nakagawa M
    Acta Haematol; 1992; 88(2-3):129-35. PubMed ID: 1281599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparative isolation of murine CD5 B cells by panning and magnetic beads.
    Metzger DW; Metzger CA; Ling LA; Hurst JS; Van Cleave VH
    Ann N Y Acad Sci; 1992 May; 651():75-7. PubMed ID: 1376090
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.
    Milani P; Palladini G; Merlini G
    Scand J Clin Lab Invest Suppl; 2016; 245():S113-8. PubMed ID: 27467897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.